Literature DB >> 16469793

Extensive DNA methylation in normal colorectal mucosa in hyperplastic polyposis.

P Minoo1, K Baker, R Goswami, G Chong, W D Foulkes, A R Ruszkiewicz, M Barker, D Buchanan, J Young, J R Jass.   

Abstract

BACKGROUND: Hyperplastic polyposis of the colorectum is a precancerous condition that has been linked with DNA methylation. The polyps in this condition have been distinguished from typical small hyperplastic polyps and renamed sessile serrated adenomas. Sessile serrated adenomas also occur sporadically and appear to be indistinguishable from their counterparts in hyperplastic polyposis. AIMS AND METHODS: The existence of distinguishing molecular features was explored in a series of serrated polyps and matched normal mucosa from patients with and without hyperplastic polyposis by assessing mutation of BRAF, DNA methylation in 14 markers (MINTs 1, 2 and 31, p16, MGMT, MLH1, RASSF1, RASSF2, NORE1 (RASSF5), RKIP, MST1, DAPK, FAS, and CHFR), and immunoexpression of MLH1.
RESULTS: There was more extensive methylation in sessile serrated adenomas from subjects with hyperplastic polyposis (p<0.0001). A more clearcut difference in patients with hyperplastic polyposis was the finding of extensive DNA methylation in normal mucosa from the proximal colon.
CONCLUSIONS: A genetic predisposition may underlie at least some forms of hyperplastic polyposis in which the earliest manifestation may be hypermethylation of multiple gene promoters in normal colorectal mucosa. Additionally, some of the heterogeneity within hyperplastic polyposis may be explained by different propensities for MLH1 inactivation within polyps.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16469793      PMCID: PMC1856423          DOI: 10.1136/gut.2005.082859

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  67 in total

1.  Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype.

Authors:  M Toyota; M Ohe-Toyota; N Ahuja; J P Issa
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

2.  The Ras effector RASSF2 is a novel tumor-suppressor gene in human colorectal cancer.

Authors:  Kimishige Akino; Minoru Toyota; Hiromu Suzuki; Hiroaki Mita; Yasushi Sasaki; Mutsumi Ohe-Toyota; Jean-Pierre J Issa; Yuji Hinoda; Kohzoh Imai; Takashi Tokino
Journal:  Gastroenterology       Date:  2005-07       Impact factor: 22.682

3.  Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer.

Authors:  Wade S Samowitz; Hans Albertsen; Jennifer Herrick; Theodore R Levin; Carol Sweeney; Maureen A Murtaugh; Roger K Wolff; Martha L Slattery
Journal:  Gastroenterology       Date:  2005-09       Impact factor: 22.682

4.  MGMT promoter methylation and field defect in sporadic colorectal cancer.

Authors:  Lanlan Shen; Yutaka Kondo; Gary L Rosner; Lianchun Xiao; Natalie Supunpong Hernandez; Jill Vilaythong; P Scott Houlihan; Robert S Krouse; Anil R Prasad; Janine G Einspahr; Julie Buckmeier; David S Alberts; Stanley R Hamilton; Jean-Pierre J Issa
Journal:  J Natl Cancer Inst       Date:  2005-09-21       Impact factor: 13.506

5.  CpG island promoter hypermethylation of a novel Ras-effector gene RASSF2A is an early event in colon carcinogenesis and correlates inversely with K-ras mutations.

Authors:  Luke B Hesson; Robin Wilson; Dion Morton; Clare Adams; Mike Walker; Eamonn R Maher; Farida Latif
Journal:  Oncogene       Date:  2005-06-02       Impact factor: 9.867

6.  Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers.

Authors:  Wade S Samowitz; Carol Sweeney; Jennifer Herrick; Hans Albertsen; Theodore R Levin; Maureen A Murtaugh; Roger K Wolff; Martha L Slattery
Journal:  Cancer Res       Date:  2005-07-15       Impact factor: 12.701

7.  Demographic and pathological characteristics of serrated polyps of colorectum.

Authors:  T Higuchi; K Sugihara; J R Jass
Journal:  Histopathology       Date:  2005-07       Impact factor: 5.087

8.  BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum.

Authors:  T Kambara; L A Simms; V L J Whitehall; K J Spring; C V A Wynter; M D Walsh; M A Barker; S Arnold; A McGivern; N Matsubara; N Tanaka; T Higuchi; J Young; J R Jass; B A Leggett
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

Review 9.  Phenotypic characteristics and risk of cancer development in hyperplastic polyposis: case series and literature review.

Authors:  Angel Ferrández; Wade Samowitz; James A DiSario; Randall W Burt
Journal:  Am J Gastroenterol       Date:  2004-10       Impact factor: 10.864

10.  Regulation of the MST1 kinase by autophosphorylation, by the growth inhibitory proteins, RASSF1 and NORE1, and by Ras.

Authors:  Maria Praskova; Andrei Khoklatchev; Sara Ortiz-Vega; Joseph Avruch
Journal:  Biochem J       Date:  2004-07-15       Impact factor: 3.857

View more
  39 in total

1.  DNA methylation in the rectal mucosa is associated with crypt proliferation and fecal short-chain fatty acids.

Authors:  Daniel L Worthley; Vicki L J Whitehall; Richard K Le Leu; Natsumi Irahara; Ronald L Buttenshaw; Kylie-Ann Mallitt; Sonia A Greco; Ingunn Ramsnes; Jean Winter; Ying Hu; Shuji Ogino; Graeme P Young; Barbara A Leggett
Journal:  Dig Dis Sci       Date:  2010-07-16       Impact factor: 3.199

Review 2.  Familial colorectal cancer type X: the other half of hereditary nonpolyposis colon cancer syndrome.

Authors:  Noralane M Lindor
Journal:  Surg Oncol Clin N Am       Date:  2009-10       Impact factor: 3.495

3.  Analysis of the association between CIMP and BRAF in colorectal cancer by DNA methylation profiling.

Authors:  Toshinori Hinoue; Daniel J Weisenberger; Fei Pan; Mihaela Campan; Myungjin Kim; Joanne Young; Vicki L Whitehall; Barbara A Leggett; Peter W Laird
Journal:  PLoS One       Date:  2009-12-21       Impact factor: 3.240

4.  The role of EGFR monoclonal antibodies (MoABs) cetuximab/panitumab, and BRAF inhibitors in BRAF mutated colorectal cancer.

Authors:  Shan Muhammad; Zheng Jiang; Zheng Liu; Kavanjit Kaur; Xishan Wang
Journal:  J Gastrointest Oncol       Date:  2013-03

Review 5.  The Role of Stem Cell DNA Methylation in Colorectal Carcinogenesis.

Authors:  Lele Song; Yuemin Li
Journal:  Stem Cell Rev Rep       Date:  2016-10       Impact factor: 5.739

Review 6.  Focus on genetic and epigenetic events of colorectal cancer pathogenesis: implications for molecular diagnosis.

Authors:  Federica Zoratto; Luigi Rossi; Monica Verrico; Anselmo Papa; Enrico Basso; Angelo Zullo; Luigi Tomao; Adriana Romiti; Giuseppe Lo Russo; Silverio Tomao
Journal:  Tumour Biol       Date:  2014-03-28

7.  A serrated colorectal cancer pathway predominates over the classic WNT pathway in patients with hyperplastic polyposis syndrome.

Authors:  Karam S Boparai; Evelien Dekker; Mirjam M Polak; Alex R Musler; Susanne van Eeden; Carel J M van Noesel
Journal:  Am J Pathol       Date:  2011-06       Impact factor: 4.307

8.  Serrated adenomas.

Authors:  Wilfredo E De Jesus-Monge; Carmen Gonzalez-Keelan; Marcia Cruz-Correa
Journal:  Curr Gastroenterol Rep       Date:  2009-10

9.  Loss of RKIP expression is associated with poor survival in GISTs.

Authors:  Olga Martinho; António Gouveia; Paula Silva; Amadeu Pimenta; Rui Manuel Reis; José Manuel Lopes
Journal:  Virchows Arch       Date:  2009-08-25       Impact factor: 4.064

10.  Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer.

Authors:  Lanlan Shen; Minoru Toyota; Yutaka Kondo; E Lin; Li Zhang; Yi Guo; Natalie Supunpong Hernandez; Xinli Chen; Saira Ahmed; Kazuo Konishi; Stanley R Hamilton; Jean-Pierre J Issa
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.